Enhanced capacitive performance of cathodically reduced titania nanotubes pulsed deposited with Mn2O3 as supercapacitor electrode

A facile and simple pulse electrodeposition method was employed to deposit Mn₂O₃ nanoparticles on cathodically reduced titania nanotubes (R-TNTs) at different deposition time in the range of 3–15 min to investigate the influence of mass loading of Mn₂O₃ on the electrochemical performance of Mn₂O₃/R-TNTs nanocomposite for supercapacitor application. Mn₂O₃ nanoparticles were deposited on circumference of R-TNTs as well as in the nanotubes as revealed by FESEM images for all the deposited time. XPS result confirmed the presence of MnO₂ (Mn⁴⁺) and MnO (Mn²⁺) on the Mn₂O₃/R-TNTs composite which provide pseudocapacitive behaviour for the electrode. Mass loading of Mn₂O₃ increased linearly with deposition time as confirmed by EDX analysis. The sample deposited for 12 min exhibits the highest areal capacitance of 51 mF cm⁻² (which is 22 times enhancement over R-TNTs) at a current density of 0.1 mA cm⁻² and specific capacitance of 325 F g⁻¹ at 6 A g⁻¹. The sample also show a high-rate capability by retaining 80% of its capacitance even at higher current density of 30 A g⁻¹. Interestingly, it retained 98% of the capacitance over 5000 charge discharge cycles at 10 A g⁻¹ after initial drop to 95% at 200th cycles suggesting an excellent long-term chemical stability. A considerably low equivalent series resistance (ESR) and charge transfer resistance (R_ct) of 9.6 Ω and 0.4 Ω respectively was deduced from electrochemical impedance spectroscopy (EIS) analysis indicating good conductivity and improved charge transfer efficiency of Mn₂O₃/R-TNTs nanocomposite.

The mass loading of Mn₂O₃ by pulse electrodeposition (PED) onto reduced titania nanotubes (R-TNTs) greatly influences the electrochemical performance of the composite.     

Relationship of Hair Regrowth Pattern in Alopecia Areata Patches According to DIMT Classification with Treatment Modalities and Patch Size: A Retrospective Cross-Sectional Analysis

BackgroundThe morphology of hair regrowth in alopecia areata (AA) patches could be classified into four types, namely diffuse, irregular, marginal, and targetoid patterns, according to the DIMT classification. However, factors affecting hair regrowth patterns have not been investigated.ObjectiveWe investigated whether the DIMT-classified hair regrowth patterns of AA patches are associated with treatment modality and patch size.MethodsWe conducted a retrospective, cross-sectional study of 152 AA patches with hair regrowth.ResultsThe associations between the diffuse pattern and patch size >2 cm (p=0.006; odds ratio [OR]: 0.36, 95% confidence interval [CI]: 0.17~0.74), between the irregular pattern and triamcinolone acetonide intralesional injection (p<0.001; OR: 274.87, 95% CI: 25.75~2,933.56), between the marginal pattern and systemic and topical corticosteroid (p=0.018; OR: 4.89, 95% CI: 1.31~18.27), and between the targetoid pattern and patch size >2 cm (p=0.028; OR: 2.50, 95% CI: 1.10~5.68) were statistically significant.ConclusionTreatment modalities and patch size are the factors affecting hair regrowth patterns in AA patches.     

Molecular Basis of Resveratrol-Induced Resensitization of Acquired Drug-Resistant Cancer Cells

Multidrug resistance (MDR) to anticancer drugs remains a serious obstacle to the success of cancer chemotherapy. Resveratrol, a polyphenol, present in natural products exerts anticancer activity and acts as a potential MDR inhibitor in various drug-resistant cancer cells. In the process of resensitization of drug-resistant cancer cells, resveratrol has been shown to interfere with ABC transporters and drug-metabolizing enzymes, increase DNA damage, inhibit cell cycle progression, and induce apoptosis and autophagy, as well as prevent the induction of epithelial to mesenchymal transition (EMT) and cancer stem cells (CSCs). This review summarizes the mechanisms by which resveratrol counteracts MDR in acquired drug-resistant cancer cell lines and provides a critical basis for understanding the regulation of MDR as well as the development of MDR-inhibiting drugs.     

The hemodynamic and pain impact of peripheral nerve block versus spinal anesthesia in diabetic patients undergoing diabetic foot surgery

Clinical Autonomic Research - Comparison of hemodynamic profiles and pain scores in diabetic patients undergoing diabetic foot surgery receiving peripheral nerve block (PNB) or spinal anesthesia...